SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011952
Filing Date
2021-05-17
Accepted
2021-05-17 17:17:50
Documents
79
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1839764
2 ex31-1.htm EX-31.1 11162
3 ex31-2.htm EX-31.2 11282
4 ex32-1.htm EX-32.1 6538
5 ex32-2.htm EX-32.2 6584
  Complete submission text file 0001493152-21-011952.txt   7910884

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vynt-20210331.xsd EX-101.SCH 50430
7 XBRL CALCULATION FILE vynt-20210331_cal.xml EX-101.CAL 78717
8 XBRL DEFINITION FILE vynt-20210331_def.xml EX-101.DEF 276415
9 XBRL LABEL FILE vynt-20210331_lab.xml EX-101.LAB 484893
10 XBRL PRESENTATION FILE vynt-20210331_pre.xml EX-101.PRE 383840
11 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1206662
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35817 | Film No.: 21932402
SIC: 8071 Services-Medical Laboratories